Mundekkad Deepa, Cho William C
Centre for NanoBioTechnology (CNBT), Vellore Institute of Technology, Vellore 632014, India.
Department of Clinical Oncology, Queen Elizabeth Hospital, Kowloon, Hong Kong SAR, China.
Pharmaceutics. 2022 Oct 24;14(11):2275. doi: 10.3390/pharmaceutics14112275.
Research on nanoparticles, especially metal nanoparticles, in cancer therapy is gaining momentum. The versatility and biocompatibility of metal nanoparticles make them ideal for various applications in cancer therapy. They can bring about apoptotic cell death in cancer cells. In addition to apoptosis, nanoparticles mediate a special type of autophagy facilitated through mitochondria called mitophagy. Interestingly, nanoparticles with antioxidant properties are capable of inducing mitophagy by altering the levels of reactive oxygen species and by influencing signaling pathways like PINK/Parkin pathway and P13K/Akt/mTOR pathway. The current review presents various roles of metal nanoparticles in inducing mitophagy in cancer cells. We envision this review sheds some light on the blind spots in the research related to mitophagy induced by nanoparticles for cancer treatment.
Pharmaceutics. 2022-10-24
Front Pharmacol. 2022-2-17
Int J Nanomedicine. 2017-3-8
Cell Death Discov. 2025-1-10
Biomater Biosyst. 2021-8-13
J Exp Clin Cancer Res. 2022-3-22
Int J Mol Sci. 2022-2-1
Drug Deliv Transl Res. 2022-11
Int J Mol Sci. 2022-1-13
Biochem Pharmacol. 2022-3